Creative Medical Technology Holdings Inc — Balance Sheet (NASDAQ:CELZ) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Total assets 717.78 K11.27 M19.19 M10.72 M6.67 M Total liabilities 40.52 M1.05 M3.32 M371.39 K327.64 K Total equity 39.8 M10.22 M15.86 M10.34 M6.34 M Total liabilities & shareholders' equities 717.78 K11.27 M19.19 M10.72 M6.67 M Total debt ————— Net debt —————

Nachrichten

Creative Medical erhält WHO-Bezeichnung für zweite Zelltherapie

Creative Medical receives WHO designation for second cell therapy

Creative Medical meldet positive Studiendaten zur Therapie von Rückenschmerzen

Creative Medical reports positive interim data for back pain therapy

Creative Medical’s BioDefense initiative receives regulatory approval

Aktionäre von Creative Medical Technology genehmigen Ausübung von Optionsscheinen

Creative Medical Technology stockholders approve warrant exercise proposal

Meilenstein für Creative Medical: Patientenrekrutierung für Studie zu chronischen Rückenschmerzen abgeschlossen

Creative Medical completes enrollment in chronic back pain trial

WHO approves olastrocel as international name for CELZ-201 therapy

Creative Medical Technology Holdings approves bonuses for CEO and CFO

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now